Trans-Pacific Multicenter Collaborative Study of Minimally Invasive Proximal Versus Total Gastrectomy for Proximal Gastric and Gastroesophageal Junction Cancers

Description

To compare the symptoms of patients who have a MIPG to the symptoms of patients who have a MITG.

Conditions

Gastrostomy, Gastric, GastroEsophageal Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

To compare the symptoms of patients who have a MIPG to the symptoms of patients who have a MITG.

Trans-Pacific Multicenter Collaborative Study of Minimally Invasive Proximal Versus Total Gastrectomy for Proximal Gastric and Gastroesophageal Junction Cancers

Trans-Pacific Multicenter Collaborative Study of Minimally Invasive Proximal Versus Total Gastrectomy for Proximal Gastric and Gastroesophageal Junction Cancers

Condition
Gastrostomy
Intervention / Treatment

-

Contacts and Locations

Rochester

Mayo Clinic in Rochester, Rochester, Minnesota, United States, 55905

Houston

M D Anderson Cancer Center, Houston, Texas, United States, 77030

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Able to speak and read English or Spanish (for patients enrolled at MD Anderson and Mayo Clinic), English or Korean (for patients enrolled at Yonsei), and English or Japanese (for patients enrolled at Keio)
  • 2. Patients with a biopsy-confirmed diagnosis of non-metastatic gastric or GEJ adenocarcinoma, who are scheduled to undergo MIPG or MITG for curative-intention
  • 3. Age ≥ 18
  • 1. Patients with known malabsorption syndromes or a lack of physical integrity of the upper gastrointestinal tract
  • 2. Patients with known narcotic dependence, with average daily dose \> 5 mg oral morphine equivalent
  • 3. Subjects deemed unable to comply with study and/or follow-up procedures, at investigators' discretion
  • 4. Patients who are pregnant (since are excluded from receiving standard-of-care MIPG or MITG)

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

M.D. Anderson Cancer Center,

Naruhiko Ikoma, MD, PRINCIPAL_INVESTIGATOR, M.D. Anderson Cancer Center

Study Record Dates

2026-05-31